Journal of Clinical Endocrinology & Metabolism, Vol 53, 1247-1250, Copyright © 1981 by Endocrine Society

ARTICLES

Reduction of plasma immunoreactive somatomedin C during fasting in humans

DR Clemmons, A Klibanski, LE Underwood, JW McArthur, EC Ridgway, IZ Beitins and JJ Van Wyk

We have assessed the effect of fasting for 10 days on plasma concentrations of immunoreactive somatomedin C and urinary urea excretion in seven obese male volunteers. From a mean prefast value of 0.83 U/ml, plasma somatomedin C fell to 0.21 U/ml after 10 days of fasting. A prompt increase was observed with refeeding. The change in somatomedin C during fasting showed a highly significant correlation with the change in urinary urea nitrogen excretion (r = 0.74; P less than 0.001). It also was shown that inhibitors which interfere with quantitation in somatomedin bioassays are not observed in the RIA for somatomedin C. The results of this study suggest that measurement of plasma somatomedin C provides a sensitive indicator of nitrogen loss and may be useful in monitoring the changes in protein metabolism that occur during alterations in nutritional status.

This article has been cited by other articles:

				C. Lofqvist, E. Andersson, L. Gelander, S. Rosberg, L. Hulthen, W. F. Blum, and K. A. Wikland Reference Values for Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) and the Ratio of Insulin-Like Growth Factor-I to IGFBP-3 throughout Childhood and Adolescence J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1420 - 1427. [Abstract] [Full Text] [PDF]

				J. A Lavigne, D. J Baer, H. H Wimbrow, P. S Albert, E. D Brown, J. T Judd, W. S Campbell, C. A Giffen, J. F Dorgan, T. J Hartman, et al. Effects of alcohol on insulin-like growth factor I and insulin-like growth factor binding protein 3 in postmenopausal women Am. J. Clinical Nutrition, February 1, 2005; 81(2): 503 - 507. [Abstract] [Full Text] [PDF]

				S. Grinspoon, K. K. Miller, D. B. Herzog, K. A. Grieco, and A. Klibanski Effects of Estrogen and Recombinant Human Insulin-Like Growth Factor-I on Ghrelin Secretion in Severe Undernutrition J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3988 - 3993. [Abstract] [Full Text] [PDF]

				S. Dolan, S. Wilkie, N. Aliabadi, M. P. Sullivan, N. Basgoz, B. Davis, and S. Grinspoon Effects of Testosterone Administration in Human Immunodeficiency Virus-Infected Women With Low Weight: A Randomized Placebo-Controlled Study Arch Intern Med, April 26, 2004; 164(8): 897 - 904. [Abstract] [Full Text] [PDF]

				E. A. Platz, M. F. Leitzmann, D. S. Michaud, W. C. Willett, and E. Giovannucci Interrelation of Energy Intake, Body Size, and Physical Activity with Prostate Cancer in a Large Prospective Cohort Study Cancer Res., December 1, 2003; 63(23): 8542 - 8548. [Abstract] [Full Text] [PDF]

				A. Decensi, U. Veronesi, R. Miceli, H. Johansson, L. Mariani, T. Camerini, M. G. Di Mauro, E. Cavadini, G. De Palo, A. Costa, et al. Relationships between Plasma Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 and Second Breast Cancer Risk in a Prevention Trial of Fenretinide Clin. Cancer Res., October 15, 2003; 9(13): 4722 - 4729. [Abstract] [Full Text] [PDF]

				S. Grinspoon, K. Miller, D. Herzog, D. Clemmons, and A. Klibanski Effects of Recombinant Human Insulin-Like Growth Factor (IGF)-I and Estrogen Administration on IGF-I, IGF Binding Protein (IGFBP)-2, and IGFBP-3 in Anorexia Nervosa: A Randomized-Controlled Study J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1142 - 1149. [Abstract] [Full Text] [PDF]

				E. Giovannucci, M. Pollak, Y. Liu, E. A. Platz, N. Majeed, E. B. Rimm, and W. C. Willett Nutritional Predictors of Insulin-like Growth Factor I and Their Relationships to Cancer in Men Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 84 - 89. [Abstract] [Full Text] [PDF]

				V. Tolle, M. Kadem, M.-T. Bluet-Pajot, D. Frere, C. Foulon, C. Bossu, R. Dardennes, C. Mounier, P. Zizzari, F. Lang, et al. Balance in Ghrelin and Leptin Plasma Levels in Anorexia Nervosa Patients and Constitutionally Thin Women J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 109 - 116. [Abstract] [Full Text] [PDF]

				M. Ozata, C. Dieguez, and F. F. Casanueva The Inhibition of Growth Hormone Secretion Presented in Obesity Is Not Mediated by the High Leptin Levels: A Study in Human Leptin Deficiency Patients J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 312 - 316. [Abstract] [Full Text] [PDF]

				E. A. Platz Energy Imbalance and Prostate Cancer J. Nutr., November 1, 2002; 132(11): 3471S - 3481. [Abstract] [Full Text] [PDF]

				C. Lofqvist, E. Andersson, L. Gelander, S. Rosberg, W. F. Blum, and K. A. Wikland Reference Values for IGF-I throughout Childhood and Adolescence: A Model that Accounts Simultaneously for the Effect of Gender, Age, and Puberty J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5870 - 5876. [Abstract] [Full Text] [PDF]

				L. Gianotti, M. Maccario, F. Lanfranco, J. Ramunni, L. Di Vito, S. Grottoli, E. E. Muller, E. Ghigo, and E. Arvat Arginine Counteracts the Inhibitory Effect of Recombinant Human Insulin-Like Growth Factor I on the Somatotroph Responsiveness to Growth Hormone-Releasing Hormone in Humans J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3604 - 3608. [Abstract] [Full Text]

				H. Yu and T. Rohan Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression J Natl Cancer Inst, September 20, 2000; 92(18): 1472 - 1489. [Abstract] [Full Text] [PDF]

				S. Bourrin, P. Ammann, J. P. Bonjour, and R. Rizzoli Dietary Protein Restriction Lowers Plasma Insulin-Like Growth Factor I (IGF-I), Impairs Cortical Bone Formation, and Induces Osteoblastic Resistance to IGF-I in Adult Female Rats Endocrinology, September 1, 2000; 141(9): 3149 - 3155. [Abstract] [Full Text] [PDF]

				H. M. Khandwala, I. E. McCutcheon, A. Flyvbjerg, and K. E. Friend The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth Endocr. Rev., June 1, 2000; 21(3): 215 - 244. [Abstract] [Full Text]

				K. E. Friedl, R. J. Moore, R. W. Hoyt, L. J. Marchitelli, L. E. Martinez-Lopez, and E. W. Askew Endocrine markers of semistarvation in healthy lean men in a multistressor environment J Appl Physiol, May 1, 2000; 88(5): 1820 - 1830. [Abstract] [Full Text] [PDF]

				I. Fukuda, M. Hotta, N. Hizuka, K. Takano, Y. Ishikawa, K. Asakawa-Yasumoto, E. Tagami, and H. Demura Decreased Serum Levels of Acid-Labile Subunit in Patients with Anorexia Nervosa J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2034 - 2036. [Abstract] [Full Text]

				E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF]

				B M D Brennan, M Gill, L Pennells, O B Eden, A G Thomas, and P E Clayton Insulin-like growth factor I, IGF binding protein 3, and IGFBP protease activity: relation to anthropometric indices in solid tumours or leukaemia Arch. Dis. Child., March 1, 1999; 80(3): 226 - 230. [Abstract] [Full Text]

				L. E. Underwood Special Considerations in the Design of Trials Involving Children J. Nutr., January 1, 1999; 129(1): 264S - 264S. [Full Text] [PDF]

				S. Grinspoon, C. Corcoran, T. Stanley, L. Katznelson, and A. Klibanski Effects of Androgen Administration on the Growth Hormone-Insulin-Like Growth Factor I Axis in Men with Acquired Immunodeficiency Syndrome Wasting J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4251 - 4256. [Abstract] [Full Text]

				N. N. Kok, L. M. Morgan, C. M. Williams, M. B. Roberfroid, J.-P. Thissen, and N. M. Delzenne Insulin, Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Insulin-Like Growth Factor I as Putative Mediators of the Hypolipidemic Effect of Oligofructose in Rats J. Nutr., July 1, 1998; 128(7): 1099 - 1103. [Abstract] [Full Text] [PDF]

				A. Carrillo, R. Rising, R. Tverskaya, and F. Lifshitz Effects of Exogenous Recombinant Human Growth Hormone on an Animal Model of Suboptimal Nutrition J. Am. Coll. Nutr., June 1, 1998; 17(3): 276 - 281. [Abstract] [Full Text] [PDF]

				W. J. Smith, L. E. Underwood, L. Keyes, and D. R. Clemmons Use of Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein Measurements to Monitor Feeding of Premature Infants J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3982 - 3988. [Abstract] [Full Text] [PDF]

				M. Scacchi, A. I. Pincelli, A. Caumo, P. Tomasi, G. Delitala, G. Baldi, and F. Cavagnini Spontaneous Nocturnal Growth Hormone Secretion in Anorexia Nervosa J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3225 - 3229. [Abstract] [Full Text] [PDF]

				I. M. Chapman, M. L. Hartman, S. S. Pezzoli, F. E. Harrell Jr., R. L. Hintz, K. G. M. M. Alberti, and M. O. Thorner Effect of Aging on the Sensitivity of Growth Hormone Secretion to Insulin-Like Growth Factor-I Negative Feedback J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2996 - 3004. [Abstract] [Full Text] [PDF]